News » FDA Approves CBD

FDA Committee Recommends Approval of Epidiolex

Incredible strides were made on April 19th when the advisory committee of the Food and Drug Administration (FDA) recommended the approval of Epidiolex, the first prescription cannabidiol medicine, as a treatment for certain severe types of epilepsy. Cannabidiol, also known as CBD, is derived from cannabis and has been receiving a lot of attention recently due to its medicinal properties. This approval represents an advancement for hemp seed oil products like ours, which are CBD extracts. About Epidiolex Epidiolex is a pharmaceutical that has been approved for the treatment of Lennox-Gastaut syndrome and Dravet syndrome in patients older than two. These extremely rare forms of epilepsy are incredibly debilitating, causing hundreds of seizures in sufferers every day. Given orally in...

Read more →